| Title |
Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab
|
|---|---|
| Published in |
HEPAC Health Economics in Prevention and Care, June 2011
|
| DOI | 10.1007/s10198-011-0323-1 |
| Pubmed ID | |
| Authors |
Thomas E. Delea, Paul Tappenden, Oleg Sofrygin, Dominy Browning, Mayur M. Amonkar, Jon Karnon, Mel D. Walker, David Cameron |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 2% |
| United Kingdom | 1 | 1% |
| Unknown | 81 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 24% |
| Student > Master | 11 | 13% |
| Other | 8 | 10% |
| Student > Ph. D. Student | 8 | 10% |
| Student > Doctoral Student | 5 | 6% |
| Other | 12 | 14% |
| Unknown | 20 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 25% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 14% |
| Economics, Econometrics and Finance | 10 | 12% |
| Agricultural and Biological Sciences | 5 | 6% |
| Nursing and Health Professions | 3 | 4% |
| Other | 10 | 12% |
| Unknown | 23 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2021.
All research outputs
#6,874,583
of 25,371,288 outputs
Outputs from HEPAC Health Economics in Prevention and Care
#449
of 1,303 outputs
Outputs of similar age
#38,063
of 127,018 outputs
Outputs of similar age from HEPAC Health Economics in Prevention and Care
#7
of 15 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,303 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,018 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.